(Q48100305)

8 February 2018

title

Challenges in screening for depression in multiple sclerosis (English)

1 reference

8 February 2018

0 references

1

1 reference

8 February 2018

author name string

Sandy Berzins

series ordinal

2

1 reference

8 February 2018

Luanne M Metz

series ordinal

3

1 reference

8 February 2018

publication date

4 August 2010

1 reference

8 February 2018

Multiple Sclerosis Journal

published in

1 reference

8 February 2018

volume

16

1 reference

8 February 2018

issue

11

1 reference

8 February 2018

page(s)

1406-1411

1 reference

8 February 2018

Major depression in multiple sclerosis: a population-based perspective

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Suicide among Danes with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Suicide and multiple sclerosis: an epidemiological investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Antidepressant pharmacotherapy of depression associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Disease management for depression in an MS clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Treatment of depression in people who have multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Clinical correlates of CES-D depressive symptom ratings in an MS population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

Should we screen for depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377770

21 January 2018

Identifiers

DOI

10.1177/1352458510377770

1 reference

8 February 2018

1 reference

8 February 2018